Memora Health

Memora Health operates an "intelligent care enablement" platform that digitizes and automates complex clinical and administrative care workflows for healthcare organizations. The company ingests an organization's existing clinical workflows and converts them into SMS-based messaging journeys that guide patients through care episodes, while automating completion of routine follow-up tasks in the EMR. Natural language processing and AI respond to common patient questions in real time and triage patient-reported concerns and data to the appropriate care team members, returning patient-reported outcomes, clinical insights and escalations to clinicians inside their existing EHR workflow.

The platform spans intelligent care management (remote patient monitoring, symptom management, patient education), clinical workflow automation (reduced inbox notifications, automated patient check-ins, patient-reported outcomes collection) and value-based care functions such as adherence tracking, VBC reporting and care team collaboration. It maintains a library of hundreds of care journeys across major specialties, including oncology, maternity/postpartum, fertility, gastroenterology and post-surgical recovery, and offers scheduling, virtual care and outcomes management tools. Memora positions text messaging as lower-friction than EHR patient apps, and states its engagement data shows no statistically significant decline in patient engagement until age 85.

Memora spun out of the Harvard Innovation Labs and participated in Y Combinator's Winter 2018 batch, initially as a text-based virtual assistant for patient discharge and follow-up management. It was acquired by Commure in December 2024 and continues to operate as part of Commure's healthcare AI software suite.

Founding story

Memora was founded in 2017 and spun out of the Harvard Innovation Labs, entering Y Combinator in the Winter 2018 batch. Its founders — Manav Sevak (CEO), Nisarg Patel (CPO) and Kunaal Naik (CTO) — built the product initially as a text-based virtual assistant helping care teams manage patient discharges and follow-ups, motivated by the absence of infrastructure in healthcare organizations for navigating a patient's full care journey and supporting care teams.

Business model

Memora sells enterprise software to healthcare organizations, which pay a monthly subscription fee for the platform. Implementation is positioned as low-lift, often beginning with a limited proof-of-concept care program before expansion into additional service lines and clinical use cases within the same organization, supported by dedicated implementation and client success teams.

Recurring monthly subscription fees paid by partner health systems, health plans and digital health companies for use of the platform's care programs.

Traction

Y Combinator lists a team size of 115. Memora reported partnerships with more than 50 healthcare organizations, revenue doubling in 2022 and headcount growing nearly fourfold that year. Company-cited program results include 85% of patient inquiries resolved by its AI assistant on its latest model, 95% patient engagement in a gastroenterology program, 96% medication adherence in an oncology program, and a 92% patient satisfaction rating in a postpartum program; in one postpartum deployment, over 32,000 messages were exchanged with fewer than 150 requiring manual clinician response.

Latest developments

In December 2024, Commure — an AI and software company backed by General Catalyst, Sequoia Capital and HCA Healthcare — acquired Memora Health for undisclosed terms, positioning Memora's care navigation alongside Commure's ambient scribe, clinical documentation and revenue cycle products. Commure had also recently acquired AI scribe company Augmedix. Following the acquisition, co-founder and former CEO Manav Sevak departed the company; CTO and co-founder Kunaal Naik remained. Memora's website directs visitors to a new site under Commure.